OBJECTIVE-This study examines the extent to which the contractile deficit of diabetic cardiomyopathy is due to altered Ca 2ϩ homeostasis.
RESEARCH DESIGN AND METHODS-Measurements of isometric force and intracellular calcium ([Ca2ϩ] i , using fura-2/AM) were made in left ventricular (LV) trabeculae from rats with streptozotocin-induced diabetes and age-matched siblings.RESULTS-At 1.5 mmol/l [Ca 2ϩ ] o , 37°C, and 5-Hz stimulation frequency, peak stress was depressed in diabetic rats (10 Ϯ 1 vs. 17 Ϯ 2 mN/mm 2 in controls; P Ͻ 0.05) with a slower time to peak stress (77 Ϯ 3 vs. 67 Ϯ 2 ms; P Ͻ 0.01) and time to 90% relaxation (76 Ϯ 7 vs. 56 Ϯ 3 ms; P Ͻ 0.05). No difference was found between groups for either resting or peak Ca 2ϩ , but the Ca 2ϩ transient was slower in time to peak (39 Ϯ 2 vs. 34 Ϯ 1 ms) and decay (time constant, 61 Ϯ 3 vs. 49 Ϯ 3 ms). Diabetic rats had a longer LV action potential (APD 50 , 98 Ϯ 5 vs. 62 Ϯ 5 ms; P Ͻ 0.0001). Western blotting showed that diabetic rats had a reduced expression of sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA)2a, with no difference in expression of the Na ϩ /Ca 2ϩ exchanger. Immunohistochemistry of LV free wall showed that type I collagen was increased in diabetic rats (diabetic 7.1 Ϯ 0.1%, control 12.7 Ϯ 0.1%; P Ͻ 0.01), and F-actin content reduced (diabetic 56.9 Ϯ 0.6%; control 61.7 Ϯ 0.4%; P Ͻ 0.0001) with a disrupted structure.CONCLUSIONS-We find no evidence to support the idea that altered Ca 2ϩ homeostasis underlies the contractile deficit of diabetic cardiomyopathy. The slower action potential and reduced SERCA2a expression can explain the slower Ca 2ϩ transient kinetics in diabetic rats but not the contractile deficit. Instead, we suggest that the observed LV remodeling may play a crucial role. Diabetes 57:2158-2166, 2008 D iabetic cardiomyopathy was first recognized by Rubler et al. (1) in diabetic patients with congestive heart failure but no evidence of coronary atherosclerosis. Prominent defects of diabetic cardiomyopathy include the prolonged duration of contraction and relaxation (Boudina and Abel [2]) and reduced cardiac compliance. The rat with streptozotocin (STZ)-induced type 1 diabetes has been widely used as a model of diabetic myopathy (3). STZ rats manifest a variety of signs of myopathy, including cardiac rhythm disturbances, prolonged contraction and/or slowed relaxation, and decreased contraction strength (4 -6). Defects in intracellular Ca 2ϩ ([Ca 2ϩ ] i ) homeostasis have been implicated in the impaired mechanical performance of the diabetic heart (7,8). However, there is no consensus in results from studies of intracellular Ca 2ϩ homeostasis performed on isolated cardiomyocytes; resting Ca 2ϩ has been shown to be decreased (9 -11), increased (12,13), or unchanged (14,15). Similarly, the amplitude of the Ca 2ϩ transient is reported as decreased (11,16 -18), increased (12), or unchanged (19,20). It is possible that this lack of consensus is due to different degrees of disease (diabetic stage) and/or experimental conditions (e.g., ...